Structure/Function Claim Opportunities For Foods Noted At IoM Forum
This article was originally published in The Tan Sheet
FDA's willingness to allow certain OTC monograph claims to be made for dietary supplements may present "market opportunities" for conventional food marketers as well, attorney Wes Siegner, Hyman, Phelps & McNamara (Washington, D.C.), suggested at an Institute of Medicine food symposium April 26.
You may also be interested in...
Some OTC drug monograph claims may be acceptable dietary supplement structure/function claims, FDA concludes in the final rule on supplement claims criteria published in the Jan. 6 Federal Register. However, others would be disease claims if used on supplement products, the agency adds.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning